CeriBell, Inc. (NASDAQ:CBLL) Given Consensus Recommendation of “Moderate Buy” by Analysts

CeriBell, Inc. (NASDAQ:CBLL) has earned an average recommendation of “Moderate Buy” from the six ratings firms that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $22.20.

CBLL has been the topic of a number of recent research reports. Weiss Ratings cut CeriBell from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday. Canaccord Genuity Group lowered their price target on CeriBell from $28.00 to $25.00 and set a “buy” rating on the stock in a report on Tuesday, May 12th.

CeriBell Stock Performance

Shares of NASDAQ CBLL opened at $17.92 on Wednesday. The company has a quick ratio of 10.01, a current ratio of 10.44 and a debt-to-equity ratio of 0.14. The stock has a market capitalization of $679.94 million, a price-to-earnings ratio of -10.99 and a beta of 0.85. The stock’s fifty day simple moving average is $18.96 and its 200 day simple moving average is $19.72. CeriBell has a 52-week low of $10.85 and a 52-week high of $24.33.

CeriBell (NASDAQ:CBLL) last issued its earnings results on Monday, May 11th. The company reported ($0.52) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.13). The company had revenue of $26.49 million during the quarter, compared to analyst estimates of $26.09 million. CeriBell had a negative return on equity of 38.19% and a negative net margin of 63.51%. As a group, sell-side analysts forecast that CeriBell will post -1.69 earnings per share for the current fiscal year.

Insider Activity

In other news, CTO Raymond Woo sold 11,112 shares of CeriBell stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $18.56, for a total transaction of $206,238.72. Following the transaction, the chief technology officer owned 166,912 shares in the company, valued at approximately $3,097,886.72. The trade was a 6.24% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Xingjuan Chao sold 39,000 shares of CeriBell stock in a transaction on Monday, June 8th. The shares were sold at an average price of $18.33, for a total value of $714,870.00. Following the transaction, the chief executive officer owned 816,317 shares in the company, valued at $14,963,090.61. This represents a 4.56% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 157,326 shares of company stock worth $2,978,499. 20.10% of the stock is owned by corporate insiders.

Institutional Trading of CeriBell

Institutional investors have recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd boosted its position in CeriBell by 3,971.0% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,262 shares of the company’s stock valued at $28,000 after purchasing an additional 1,231 shares during the last quarter. Strs Ohio acquired a new stake in CeriBell during the first quarter valued at $27,000. CWM LLC boosted its position in CeriBell by 1,178.5% during the fourth quarter. CWM LLC now owns 1,841 shares of the company’s stock valued at $40,000 after purchasing an additional 1,697 shares during the last quarter. Tower Research Capital LLC TRC boosted its position in CeriBell by 353.8% during the second quarter. Tower Research Capital LLC TRC now owns 2,310 shares of the company’s stock valued at $43,000 after purchasing an additional 1,801 shares during the last quarter. Finally, Larson Financial Group LLC boosted its position in CeriBell by 1,403.1% during the fourth quarter. Larson Financial Group LLC now owns 2,871 shares of the company’s stock valued at $63,000 after purchasing an additional 2,680 shares during the last quarter.

About CeriBell

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.